PTGS2 and non-small cell lung carcinoma: They reported lowering the rate of proliferation, suppressing the PI3K/Akt pathway and changing the NF-kB and cyclooxygenase-2 expression in the nude mice model implanted with non-small cell lung carcinoma A549 cells.